Pulmonary Thromboembolism after Post-menopause Hormonal Replacement Therapy
![]() ![]() |
Kim, Sun Young
(Department of Internal Medicine, Inje University)
Park, Jong Hyeok (Department of Internal Medicine, Inje University) Lee, Hyun Kyung (Department of Internal Medicine, Inje University) Lee, Hyuk Pyo (Department of Internal Medicine, Inje University) Lee, Hye Kyung (Department of Pathology, Inje University) Choi, Soo Jeon (Department of Internal Medicine, Inje University) Yum, Ho-Kee (Department of Internal Medicine, Inje University) |
1 | Barlow DH. Hormone replacement therapy and the risk of deep vein thrombosis. Int J Gynecol Obstet 1997;59:S29-S33 DOI ScienceOn |
2 | Gerstman EB, Piper JJM, Tomita DK, Ferguoon WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991;133:32-7 DOI |
3 | Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-80 DOI ScienceOn |
4 | Vessay M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboemholism: findings in a large prospective study. Br Med J 1983;292:526 DOI |
5 | Gerstman BB, Piper JM, Freiman JP, Tomita DR, Kennedy DL, Ferguson WJ, et al. Oral contruceptive estrogen and progestin potencies and the incidence of deep venous thromboembolism. Int J Epidemiol 1990;19:931-6 DOI |
6 | Lidegaard O, Edstrim B, Kreiner S. Oral contraceptives and venous thromboemholism. A case-control study. Contraception 1998;57:291-301 DOI ScienceOn |
7 | Jick H, Derby LE, Myers MW, Vasi!akis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1993;348:931-3 |
8 | Scarahin PY, Oger E, Plu-Bureau G. Differential association of oral and transderkmal oestmgen-replacement therapy with venous thromboemholism risk. Lancet 2003;362:428-32 DOI |
9 | Bae SJ, Kim JS, Kim JH, Yun YJ, Lee SA A case of venous thrombosis developed in a woman taking oral contraceptives with antithrombin III, protein C and protein 8 deficiencies. Korean J Obstet Gynecol 2003;49:1383-8 |
10 | Douketis JD, Julian JA, Keamn C, Anderson DR, Crowther MA, Bates SM, et al. The, the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromh Haemost 2005;3:943-8 DOI ScienceOn |
11 | Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy. JAMA 2002;288:872-81 DOI ScienceOn |
12 | Wu O. Pbstmenopausal hormone replacement therapy and venous thromboembolism. Gender Medicine 2005;2:S18-S27 DOI ScienceOn |
![]() |